Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference27 articles.
1. Febrile Neutropenia Study Group. Guidelines for diagnosis and treatment of neutropenic patients. Flora. 2004;9:5–28.
2. Alp S, Akova M. Management of febrile neutropenia in the era of bacterial resistance. Ther Adv Infect Dis. 2013;1:37–43.
3. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:427–31.
4. Ozden M, Denk A, Demirdag K, et al. Investigation of febrile neutropenic cases and risk factors. Mediterr J Infect Microb Antimicrob. 2013;2:3.
5. Oztoprak N, Piskin N, Aydemir H, et al. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital. Jpn J Clin Oncol. 2010;40:761–7.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献